CStone Pharmaceuticals — Share Issue/Capital Change 2019

Feb 13, 2019

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

This Application Form uses the same terms as defined in the prospectus of CStone Pharmaceuticals (the “ Company ”) dated Thursday, February 14, 2019 (the “ Prospectus ”). Staple your 本申請表格使用基石藥業（「 本公司 」）於二零一九年二月十四日（星期四）刊發的招股章程（「 招股章程 」）所 payment 界定的詞語。 here Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong Kong Offer Shares in any jurisdiction other than Hong Kong. The Hong Kong Offer Shares may 請將股款 not be offered or sold in the United States without registration or an exemption from registration under the U.S. 緊釘在此 Securities Act. 本申請表格及招股章程概不構成在香港以外司法管轄權區要約出售或游說要約購買香港發售股份。若無根 據美國證券法登記或豁免登記，香港發售股份不得在美國提呈發售或出售。 This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in any manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under the law of that jurisdiction. 在任何根據當地法例不得發送、派發或複製本申請表格及招股章程的司法管轄權區內概不得發送或派發或 複製（不論方式，也不論全部或部分）本申請表格及招股章程。 Copies of the Prospectus, all related Application Forms and the other documents specified in the “Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection – Documents Delivered to the Registrar of Companies” section in Appendix VI to the Prospectus, have been registered by the Registrar of Companies in Hong Kong as required by Section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “ Stock Exchange ”), Hong Kong Securities Clearing Company Limited (“ HKSCC ”), the Securities and Futures Commission of Hong Kong (the “ SFC ”) and the Registrar of Companies of Hong Kong take no responsibility for the contents of these documents. 招股章程、所有相關申請表格及招股章程附錄六「送呈香港公司註冊處處長及備查文件－送呈公司註冊處 處長文件」一節所述其他文件已遵照第32章公司（清盤及雜項條文）條例第342C條的規定，送呈香港公司註 冊處處長登記。香港交易及結算所有限公司、香港聯合交易所有限公司（「 聯交所 」）、香港中央結算有限公 司（「 香港結算 」）、香港證券及期貨事務監察委員會（「 證監會 」）及香港公司註冊處處長對此等文件的內容 概不負責。 CStone Pharmaceuticals 基石藥業 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） Stock Code : 2616 股份代號 : 2616 Maximum Offer Price : HK$12.80 per Offer Share plus brokerage of 1.0%, SFC transaction levy of 0.0027% and the Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars and subject to refund) 最高發售價 : 每股發售股份12.80港元，另加1.0%經紀佣金、 0.0027%證監會交易徵費及0.005%聯交所交易費 （須於申請時以港元繳足，多繳股款可予退還） You should read this Application Form in conjunction with the Prospectus, which contains further information on the application procedures. ， 一 。 招股章程尚有關於申請程序的其他資料 本申請表格應與招股章程 併閱讀 Application Form 申請表格 To: CStone Pharmaceuticals 致： 基石藥業 Joint Sponsors 聯席保薦人 Joint Global Coordinators 聯席全球協調人 Joint Bookrunners 聯席賬簿管理人 Hong Kong Underwriters 香港包銷商

致： 基石藥業 聯席保薦人 聯席全球協調人 聯席賬簿管理人 香港包銷商 申請人聲明

Applicants’ declaration

~~本~~ 人 ~~╱~~ 吾 ~~等~~ 同意本申請表格及招股章程的條款及條件以 及申請程序。請參閱本申請表格「填交本申請表格的效 用」一節。

I/We agree to the terms and conditions and application procedures in this Application Form and the Prospectus. Please refer to the “Effect of completing and submitting this Application Form” section of this Application Form.

警告：任何人士只限作出一次為其利益而進行的認購申 ~~請~~ 。 ~~請參~~ 閱 ~~本申請表格「填交本申請表格的效~~ 用 ~~」~~ 一 ~~節~~ 最 ~~後~~ 四點。

Warning: Only one application may be made for the benefit of any person. Please refer to the last four bullets of “Effect of completing and submitting this Application Form” section.

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

Signed by (all) applicant(s) (all joint applicants must sign): 由（所有）申請人簽署（所有聯名申請人必須簽署）：

For Broker use 此欄供經紀填寫 Lodged by 遞交申請的經紀 由（所有）申請人簽署（所有聯名申請人必須簽署）： Broker No. 經紀號碼 Broker’s Chop 經紀印章 Date 日期： / / D日 M月 Y年 Number of Hong Kong Offer Shares applied for (not more than Cheque/banker’s cashier order number 支票 ╱ 銀行本票號碼 9,320,000 Shares) 申請香港發售股份數目（不超過9,320,000股股份） Name of bank on which cheque/banker’s cashier order is drawn (see “How to make your application” section) 兌現支票 ╱ 銀行本 Total amount 總額 票的銀行名稱（見「申請手續」一節） HK$ 港元 Name in English (in BLOCK letters) 英文姓名╱名稱（正楷） Family name or company name 姓氏或公司名稱 Forename(s) 名字 Name in Chinese 中文姓名╱名稱 Family name or company name 姓氏或公司名稱 Forename(s) 名字 Occupation in English 職業（以英文填寫） Hong Kong Identity Card No./Passport No./Hong Kong Business Registration No. (Please delete as appropriate) 香港身份證號碼╱護 照號碼╱香港商業登記號碼（請刪除不適用者） Names of all other joint applicants in English (if any, in BLOCK letters) Hong Kong Identity Card No./Passport No./Hong Kong Business Registration No. of all other joint applicants (Please delete as appropriate) 所有其他聯名申請人 所有其他聯名申請人的英文姓名╱名稱（如有，正楷） * 的香港身份證號碼╱護照號碼╱香港商業登記號碼 （請刪除不適用者） 1) 1) 2) 2) 3) 3) Hong Kong address in English and telephone no. (joint applicants should give the address and the telephone number of first-named applicant only in BLOCK letters) 香港地址（以英文正楷填寫）及電話號碼（聯名申請人只須填寫排名首位申請人的地址及電話號碼） Telephone No. 電話號碼 For Nominees: You will be treated as applying for your own benefit if you do not complete this section. Please provide an account number or identification code for each (joint) beneficial owner. 由代名人遞交：代名人若不填寫本節，是項 認購申請將視作為 閣下利益提出。請填寫每名（聯名）實 益擁有人的賬戶號碼或識別編碼。 ADDRESS LABEL 地址標貼 (Your name(s) and address in Hong Kong in BLOCK letters 請用英文正楷填寫 姓名╱名稱 及香港 地址* )

For internal use 此欄供內部使用

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

• *(1) An individual must provide his Hong Kong Identity Card number or, if he does not hold a Hong Kong Identity Card, his passport number. A body corporate must provide its Hong Kong Business Registration number. Each joint applicant must provide its or his relevant number. The Hong Kong Identity Card number(s)/passport number(s)/Hong Kong Business Registration number(s) will be transferred to a third party for checking the Application Form’s validity.

個別人士須填寫其香港身份證號碼或（如非香港身份證持有人）護照號碼。法人團體須填寫其香港 商業登記號碼。每名聯名申請人均須提供其相關號碼。該等香港身份證號碼╱護照號碼╱香港商 業登記號碼將轉交第三方以核實申請表格的有效性。 (2) Part of the Hong Kong Identity Card number/passport number of you or, for joint applicants, the firstnamed applicant may be printed on your refund cheque (if any). Your banker may require verification of your Hong Kong Identity Card number/passport number before you can cash your refund cheque. 日後如需退回申請股款，退款支票上或會印有 閣下或（如屬聯名申請人）排名首位申請人的香港 身份證號碼╱護照號碼的一部分。銀行兌現退款支票前或會要求查證 閣下的香港身份證號碼╱ 護照號碼。 (3) If an application is made by an unlisted company and: • the principal business of that company is dealing in securities; and • you exercise statutory control over that company, then the application will be treated as being made for your benefit. 倘若申請人是一家非上市公司，而： • 該公司主要從事證券買賣業務；及 • 閣下對該公司可行使法定控制權， 是項申請將視作為 閣下的利益提出。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

Mixed Media Offer

混合媒介要約

The Company will be relying on Section 9A of 本公司將依據第32L章《公司（豁免公司及招股 the Companies (Exemption of Companies and 章程遵從條文）公告》第9A條，在並非與招股章 Prospectuses from Compliance with Provisions) 程印刷本一併發出的情況下，發出 白色 及 黃色 Notice (Cap. 32L) and will be issuing the WHITE 申請表格。招股章程印刷本的內容與招股章程的 and YELLOW Application Forms without them 電子版本相同，招股章程的電子版本可分別在本 being accompanied by a printed Prospectus. The 公司網站 www.cstonepharma.com 及聯交所網站 contents of the printed Prospectus are identical to www.hkexnews.hk 「披露易＞上市公司公告＞最 the electronic version of the Prospectus which can 新上市公司公告」查閱及下載。 be accessed and downloaded from the websites of the Company at www.cstonepharma.com and the Stock Exchange at www.hkexnews.hk under the “ HKExnews > Listed Company Information > Latest Listed Company Information ” section, respectively. Members of the public may obtain a copy of the 公眾人士可於二零一九年二月十四日（星期四）上 printed Prospectus, free of charge, upon request 午九時正至二零一九年二月十九日（星期二）中午 during normal business hours from 9:00 a.m. on 十二時正的正常辦公時間內，在以下地點免費索 Thursday, February 14, 2019 until 12:00 noon 取招股章程印刷本： on Tuesday, February 19, 2019 at the following locations: 1. any of the following branches of the receiving 1. 本公司收款銀行的下列任何分行： bank of the Company: Standard Chartered Bank (Hong Kong) Limited 渣打銀行（香港）有限公司 Branch Name Address 分行名稱 地址 Hong Kong Island 188 Des Voeux Road Shop No. 7 on G/F 香港島 188德輔道中分行 香港德輔道中188號 Branch Whole of 1/F – 3/F Golden Centre 金龍中心 188 Des Voeux Road Central 地下7號舖，1樓至3樓全層 Hong Kong 銅鑼灣分行 銅鑼灣怡和街38-40A號 Causeway Bay Branch G/F to 2/F, Yee Wah Mansion 怡華大廈地下至2樓 38-40A Yee Wo Street 九龍區 旺角分行 旺角彌敦道617-623號 Causeway Bay 地下B舖，一樓及二樓 Kowloon Mongkok Branch Shop B, G/F, 1/F & 2/F 68彌敦道分行 尖沙咀彌敦道66-70號 617-623 Nathan Road 金冠大廈地庫、地下B1號舖及中層 Mongkok 新界區 元朗豐年路分行 元朗青山公路段239-247及247A號 68 Nathan Road Branch Basement, Shop B1 萬昌樓地下前舖Ｂ號及一樓全層 G/F and M/F Golden Crown Court 66-70 Nathan Road Tsimshatsui New Territories Yuen Long Fung Nin Shop B at G/F and 1/F Road Branch Man Cheong Building 239-247&247A Castle Peak Road Yuen Long

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

1. any of the following offices of the Hong Kong Underwriters:

2. 香港包銷商以下任何辦事處：

3. (a) Goldman Sachs (Asia) L.L.C. , at 59/F, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong;

4. (a) 高盛（亞洲）有限責任公司 ，地址為香 港中環皇后大道中2號長江集團中心59 樓；

(b) Morgan Stanley Asia Limited , at 46/F, (b) 摩根士丹利亞洲有限公司 ，地址為香 International Commerce Centre, 1 Austin 港九龍柯士甸道西1號環球貿易廣場46 Road West Kowloon, Hong Kong; 樓； (c) UBS AG Hong Kong Branch , at 52/F, (c) UBS AG香港分行 ，地址為香港中環金 Two International Finance Centre, 8 融街8號國際金融中心二期52樓；及 Finance Street, Central, Hong Kong; and (d) China Merchants Securities (HK) Co. , (d) 招商證券（香港）有限公司 ，地址為香 Limited, at 48/F, One Exchange Square, 港中環交易廣場一期48樓；及 Central, Hong Kong; and 3. the Depository Counter of HKSCC at 1/F, One 3. 香港結算存管處服務櫃檯，地址為香港中環 & Two Exchange Square, 8 Connaught Place, 康樂廣場8號交易廣場一座及二座一樓。 Central, Hong Kong. Details of where printed Prospectuses may 可索取招股章程印刷本的地址詳情將於派發白色 。 be obtained will be displayed prominently at 及黃色申請表格的各個地點以顯眼方式展示 every location where WHITE and YELLOW Application Forms are distributed. During normal business hours from 9:00 a.m. on 於二零一九年二月十四日（星期四）上午九時正至 Thursday, February 14, 2019 until 12:00 noon on 二零一九年二月十九日（星期二）中午十二時正的 Tuesday, February 19, 2019, at least three copies 正常辦公時間內，在派發 白色 及 黃色 申請表格的 of the printed Prospectus will be available for 各個地點（載於招股章程「如何申請香港發售股 inspection at every location where the WHITE and 份」），均有至少三份招股章程印刷本可供查閱。 YELLOW Application Forms are distributed as set out in “ How to Apply for Hong Kong Offer Shares ” in the Prospectus.

This page is intentionally left blank 此乃白頁 特意留空

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

How to make your application

1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 500 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.

NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS

		NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS
		No. of Amount No. of Amount No. of Amount No. of Amount
2. 3.		Hong Kong Offer Shares applied for payable on application HK$ Hong Kong Offer Shares applied for payable on application HK$ Hong Kong Offer Shares applied for payable on application HK$ Hong Kong Offer Shares applied for payable on application HK$ 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 5,000 6,000 7,000 6,464.49 12,928.99 19,393.48 25,857.97 32,322.46 38,786.96 45,251.45 51,715.94 58,180.44 64,644.93 77,573.91 90,502.90 8,000 9,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 50,000 60,000 103,431.88 116,360.87 129,289.86 193,934.78 258,579.71 323,224.64 387,869.57 452,514.50 517,159.42 581,804.35 646,449.28 775,739.14 70,000 80,000 90,000 100,000 200,000 300,000 400,000 500,000 600,000 700,000 800,000 900,000 905,028.99 1,034,318.85 1,163,608.70 1,292,898.56 2,585,797.12 3,878,695.68 5,171,594.24 6,464,492.80 7,757,391.36 9,050,289.92 10,343,188.48 11,636,087.04 1,000,000 2,000,000 3,000,000 4,000,000 5,000,000 6,000,000 7,000,000 8,000,000 9,000,000 9,320,000(1) 12,928,985.60 25,857,971.20 38,786,956.80 51,715,942.40 64,644,928.00 77,573,913.60 90,502,899.20 103,431,884.80 116,360,870.40 120,498,145.79 (1)Maximum number of Hong Kong Offer Shares you may apply for. Complete the form in English in BLOCK letters and sign it. Only written signatures will be accepted (and not by way of personal chop). Staple your cheque or banker’s cashier order to the form. Each application for the Hong Kong Offer Shares must be accompanied by either one separate cheque or one separate banker’s cashier order. Your application will be rejected if your cheque or banker’s cashier order does not meet all the following requirements: The cheque must: Banker’s cashier order must: • be in Hong Kong dollars; • not be post-dated; • be made payable to “Horsford Nominees Limited – CStone Pharmaceuticals Public Offer”; • be crossed “Account Payee Only”; • be drawn on your Hong Kong dollar bank account in Hong Kong; and • be issued by a licensed bank in Hong Kong, and have your name certified on the Sample 樣版
		• show your account name, which must back by a person authorised by the bank.
		either be pre-printed on the cheque, or The name on the banker’s cashier order
		be endorsed on the back by a person must correspond with your name. If it is
		authorised by the bank. This account name a joint application, the name on the back
		must correspond with your name. If it is a of the banker’s cashier order must be the
		joint application, the account name must same as the first-named applicant’s name.
		be the same as the first-named applicant’s
		name.

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

1. Tear off the Application Form, fold it once and lodge your completed Application Form (with cheque or banker’s cashier order attached) to one of the collection boxes at any of the following branches of: Standard Chartered Bank (Hong Kong) Limited Branch Name Address Hong Kong Island 188 Des Voeux Road Branch Shop No. 7 on G/F Whole of 1/F – 3/F Golden Centre 188 Des Voeux Road Central Hong Kong Causeway Bay Branch G/F to 2/F, Yee Wah Mansion 38-40A Yee Wo Street Causeway Bay Kowloon Mongkok Branch Shop B, G/F, 1/F & 2/F 617-623 Nathan Road Mongkok 68 Nathan Road Branch Basement, Shop B1 G/F and M/F Golden Crown Court 66-70 Nathan Road Tsimshatsui New Territories Yuen Long Fung Nin Road Branch Shop B at G/F and 1/F Man Cheong Building 239-247&247A Castle Peak Road Yuen Long 5. Your Application Form can be lodged at these times: – Thursday, February 14, 2019 9:00 a.m. to 5:00 p.m. – Friday, February 15, 2019 9:00 a.m. to 5:00 p.m. – Saturday, February 16, 2019 9:00 a.m. to 1:00 p.m. – Monday, February 18, 2019 9:00 a.m. to 5:00 p.m. Tuesday, February 19, 2019 – 9:00 a.m. to 12:00 noon 6. The latest time for lodging your application is 12:00 noon on Tuesday, February 19, 2019. The application lists will be opened between 11:45 a.m. to 12:00 noon on that day, subject only to the weather conditions, as described in “Effect of Bad Weather on the Opening of the Application Lists” in the “How to Apply for Hong Kong Offer Shares” section of the Prospectus. The applications for the Hong Kong Offer Shares will commence on Thursday, February 14, 2019 through Tuesday, February 19, 2019. The application monies (including the brokerage fees, SFC transaction levies and Stock Exchange trading fees) will be held by the receiving bank and on behalf of the Company after the closing of the application lists and the refund monies, if any, will be returned to the applicants without interest on or before Monday, February 25, 2019. Investors should be aware that the dealings in the Shares on the Stock Exchange are expected to commence on Tuesday, February 26, 2019.

– Thursday, February 14, 2019 9:00 a.m. to 5:00 p.m. – Friday, February 15, 2019 9:00 a.m. to 5:00 p.m. – Saturday, February 16, 2019 9:00 a.m. to 1:00 p.m. – Monday, February 18, 2019 9:00 a.m. to 5:00 p.m. Tuesday, February 19, 2019 – 9:00 a.m. to 12:00 noon 6. The latest time for lodging your application is 12:00 noon on Tuesday, February 19, 2019. The application lists will be opened between 11:45 a.m. to 12:00 noon on that day, subject only to the weather conditions, as described in “Effect of Bad Weather on the Opening of the Application Lists” in the “How to Apply for Hong Kong Offer Shares” section of the Prospectus.

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

申請手續

1. 使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為500股香港發售股份，並為下表 所列的其中一個數目，否則恕不受理。

可供申請認購股份數目及應繳款項

申請認購的 申請時 申請認購的 申請時 申請認購的 申請時 申請認購的 申請時 香港發售 應繳款項 香港發售 應繳款項 香港發售 應繳款項 香港發售 應繳款項 股份數目 港元 股份數目 港元 股份數目 港元 股份數目 港元 500 6,464.49 8,000 103,431.88 70,000 905,028.99 1,000,000 12,928,985.60 1,000 12,928.99 9,000 116,360.87 80,000 1,034,318.85 2,000,000 25,857,971.20 1,500 19,393.48 10,000 129,289.86 90,000 1,163,608.70 3,000,000 38,786,956.80 2,000 25,857.97 15,000 193,934.78 100,000 1,292,898.56 4,000,000 51,715,942.40 2,500 32,322.46 20,000 258,579.71 200,000 2,585,797.12 5,000,000 64,644,928.00 3,000 38,786.96 25,000 323,224.64 300,000 3,878,695.68 6,000,000 77,573,913.60 3,500 45,251.45 30,000 387,869.57 400,000 5,171,594.24 7,000,000 90,502,899.20 4,000 51,715.94 35,000 452,514.50 500,000 6,464,492.80 8,000,000 103,431,884.80 4,500 58,180.44 40,000 517,159.42 600,000 7,757,391.36 9,000,000 116,360,870.40 5,000 64,644.93 45,000 581,804.35 700,000 9,050,289.92 9,320,000[(1)] 120,498,145.79 6,000 77,573.91 50,000 646,449.28 800,000 10,343,188.48 (1) 閣下可申請認購的香港發售股份最高 7,000 90,502.90 60,000 775,739.14 900,000 11,636,087.04 數目。 2. 以英文正楷填妥及簽署申請表格。只接納親筆簽名（不得以個人印章代替）。 3. 閣下須將支票或銀行本票釘於表格上。每份香港發售股份申請須附一張獨立開出支票或一張獨立 開出銀行本票。支票或銀行本票必須符合以下所有規定，否則有關的認購申請不獲接納： 支票必須： 銀行本票必須： • 為港元； • 不得為期票； • 註明抬頭人為「 浩豐代理人有限公司－基石藥業公開發售 」； • 劃線註明「只准入抬頭人賬戶」； • 從 閣下在香港的港元銀行賬戶中開 • 須由香港持牌銀行開出，並由有關銀 出；及 行授權的人士在銀行本票背面簽署核 • 顯示 閣下的賬戶名稱，而該賬戶名稱 證 閣下姓名╱名稱。銀行本票所示 必須已預印在支票上，或由有關銀行授 姓名╱名稱須與 閣下姓名╱名稱相 權的人士在支票背書。賬戶名稱必須 同。如屬聯名申請，銀行本票背面所示 與 閣下姓名╱名稱相同。如屬聯名申 姓名╱名稱必須與排名首位申請人的姓 請，賬戶名稱必須與排名首位申請人的 名╱名稱相同。 姓名╱名稱相同。

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

1. 請撕下申請表格，對摺一次，然後將填妥的申請表格（連同支票或銀行本票）投入下列任何一家分 行特設的收集箱：

渣打銀行（香港）有限公司 分行名稱 地址 香港島 188德輔道中分行 香港德輔道中188號 金龍中心 地下7號舖，1樓至3樓全層 銅鑼灣分行 銅鑼灣怡和街38-40A號 怡華大廈地下至2樓 九龍區 旺角分行 旺角彌敦道617-623號 地下B舖，一樓及二樓 68彌敦道分行 尖沙咀彌敦道66-70號 金冠大廈地庫、地下B1號舖及中層 新界區 元朗豐年路分行 元朗青山公路段239-247及247A號 萬昌樓地下前舖Ｂ號及一樓全層 5. 閣下可於下列時間遞交申請表格： 二零一九年二月十四日（星期四）－上午九時正至下午五時正 二零一九年二月十五日（星期五）－上午九時正至下午五時正 二零一九年二月十六日（星期六）－上午九時正至下午一時正 二零一九年二月十八日（星期一）－上午九時正至下午五時正 二零一九年二月十九日（星期二）－上午九時正至中午十二時正 6. 截止遞交申請的時間為二零一九年二月十九日（星期二）中午十二時正。本公司將於當日上午十一 時四十五分至中午十二時正期間登記認購申請，唯一會影響此時間的變化因素為當日的天氣情況 （詳見招股章程「如何申請香港發售股份」一節「惡劣天氣對開始辦理申請登記的影響」）。 香港發售股份申請將會自二零一九年二月十四日（星期四）起直至二零一九年二月十九日（星期二） 止。申請款項（包括經紀佣金、證監會交易徵費及聯交所交易費）將由收款銀行於截止辦理申請登 記後代表本公司持有，且退款金額（如有）將於二零一九年二月二十五日（星期一）或之前不計利 息退還予申請人。投資者務請注意，預期股份將於二零一九年二月二十六日（星期二）於聯交所開 始買賣。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

==> picture [116 x 37] intentionally omitted <==

CStone Pharmaceuticals 基石藥業

(Incorporated in the Cayman Islands with limited liability) GLOBAL OFFERING Conditions of your application • confirm that you are aware of the restrictions on the Global A. Who can apply Offering in the Prospectus; 1. You and any person(s) for whose benefit you are applying • agree that none of the Company, the Relevant Persons and must be 18 years of age or older and must have a Hong Kong the White Form eIPO Service Provider is or will be liable address. for any information and representations not in the Prospectus 2. If you are a firm, the application must be in the individual (and any supplement to it); members’ names. • undertake and confirm that you or the person(s) for whose 3. The number of joint applicants may not exceed four. benefit you have made the application have not applied for 4. If you are a body corporate, the application must be or taken up, or indicated an interest for, and will not apply signed by a duly authorised officer, who must state his for or take up, or indicate an interest for, any Offer Shares representative capacity, and stamped with your corporation’s under the International Offering nor participated in the chop. International Offering; 5. You must be outside the United States, not be a United • agree to disclose to the Company, the Hong Kong Share States Person (within the meaning of Regulation S under the Registrar, receiving bank and the Relevant Persons any U.S. Securities Act) or a person described in paragraph (h)(3) personal data which they may require about you and the of Rule 902 of Regulation S under the U.S. Securities Act person(s) for whose benefit you have made the application; and not be a legal or natural person of the PRC. • if the laws of any place outside Hong Kong apply to your 6. Unless permitted by the Listing Rules or any relevant application, agree and warrant that you have complied with waivers that have been granted by the Stock Exchange, you all such laws and none of the Company nor the Relevant cannot apply for any Hong Kong Offer Shares if you are: Persons will breach any law outside Hong Kong as a result • an existing beneficial owner of shares in the Company of the acceptance of your offer to purchase, or any action and/or any of its subsidiaries; arising from your rights and obligations under the terms and • a close associate of any of the above; conditions contained in the Prospectus and this Application • a Director or chief executive officer of the Company Form; and/or any of its subsidiaries; • agree that once your application has been accepted, you may • a connected person of the Company or will become a not rescind it because of an innocent misrepresentation; connected person of the Company immediately upon • agree that your application will be governed by the laws of completion of the Global Offering; or Hong Kong; • have been allocated or have applied for or indicated • represent , warrant and undertake that (i) you understand an interest in any Offer Shares under the International that the Hong Kong Offer Shares have not been and will not Offering. be registered under the U.S. Securities Act; and (ii) you and any person for whose benefit you are applying for the Hong B. If you are a nominee Kong Offer Shares are outside the United States (as defined You, as a nominee, may make more than one application for the in Regulation S) or are a person described in paragraph (h) Hong Kong Offer Shares by: (i) giving electronic instructions to (3) of Rule 902 of Regulation S; HKSCC via Central Clearing and Settlement System (“CCASS”) • warrant that the information you have provided is true and (if you are a CCASS Participant); or (ii) using a WHITE or accurate; YELLOW Application Form, and lodge more than one application • agree to accept the Hong Kong Offer Shares applied for, or in your own name on behalf of different beneficial owners. any lesser number allocated to you under the application; • authorise the Company to place your name(s) on the C. Effect of completing and submitting this Application Company’s register of members as the holder(s) of any Form Hong Kong Offer Shares allocated to you, and the Company By completing and submitting this Application Form, you (and and/or its agents to send any share certificate(s) and/or if you are joint applicants, each of you jointly and severally) for any refund cheque(s) to you or the first-named applicant yourself or as an agent or a nominee on behalf of each person for for joint application by ordinary post at your own risk whom you act: to the address stated on the application, unless you have • undertake to execute all relevant documents and instruct and fulfilled the criteria set out in “Personal Collection” in the authorise the Company and/or the Joint Global Coordinators “How to Apply for Hong Kong Offer Shares” section in the (or their agents or nominees), as agents of the Company, to Prospectus to collect the share certificate(s) and/or refund execute any documents for you and to do on your behalf all cheque(s) in person; things necessary to register any Hong Kong Offer Shares • understand that, in accordance with Guidance Letter allocated to you in your name as required by the Articles of HKEX-GL91-18 issued by the Stock Exchange, where Association; the International Offer Shares are undersubscribed and the

• understand that, in accordance with Guidance Letter HKEX-GL91-18 issued by the Stock Exchange, where the International Offer Shares are undersubscribed and the Hong Kong Offer Shares are oversubscribed irrespective of the number of times, up to 18,640,000 Offer Shares may be reallocated to the Hong Kong Public Offering from the International Offering, so that the total number of the Shares available under the Hong Kong Public Offer will be increased to 37,280,000 Offer Shares, representing approximately 20% of the number of the Offer Shares initially available under the Global Offering (before any exercise of the Over-allotment Option), and the final Offer Price shall be fixed at the low-end of the indicative Offer Price range (i.e. HK$11.10 per Offer Share) as stated in the Prospectus. Further details of the

• agree to comply with the Companies Ordinance (Cap. 622), the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) and the Articles of Association;

• confirm that you have read the terms and conditions and application procedures set out in the Prospectus and in this Application Form and agree to be bound by them;

• confirm that you have received and read the Prospectus and have only relied on the information and representations contained in the Prospectus in making your application and will not rely on any other information or representations except those in any supplement to the Prospectus;

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

If you do not collect your refund cheque(s) and/or Share certificate(s) personally within the time period specified for collection, they will be dispatched promptly to the address as specified on this Application Form by ordinary post at your own risk.

• reallocation are stated in the paragraph headed “Structure of the Global Offering — Hong Kong Public Offering – Reallocation and Clawback” of the Prospectus;

• understand that the Company and the Joint Global Coordinators will rely on your declarations and representations in deciding whether or not to make any allotment of any of the Hong Kong Offer Shares to you and that you may be prosecuted for making a false declaration;

If you apply for less than 1,000,000 Hong Kong Offer Shares, your refund cheque(s) and/or Share certificate(s) will be sent to the address on the relevant Application Form on or before Monday, February 25, 2019, by ordinary post and at your own risk.

• declare and represent that this is the only application made and the only application intended by you to be made to Monday, February 25, 2019, by ordinary post and at your own benefit you or the person for whose benefit you are applying; risk. • (if the application is made for your own benefit) warrant Refund of your money that no other application has been or will be made for your benefit on a WHITE or YELLOW Application Form or by If you do not receive any Hong Kong Offer Shares or if your application is accepted only in part, the Company will refund to giving electronic application instructions to HKSCC or to the White Form eIPO Service Provider by you or by any you your application monies (including the related 1% brokerage, 0.0027% SFC transaction levy and 0.005% Stock Exchange one as your agent or by any other person; and • (if you are making the application as an agent for the benefit trading fee) without interest. If the Offer Price is less than the of another person) warrant that (i) no other application has maximum Offer Price, the Company will refund to you the surplus application monies (including the related 1% brokerage, 0.0027% been or will be made by you as agent for or for the benefit of SFC transaction levy and 0.005% Stock Exchange trading fee) that person or by that person or by any other person as agent without interest. for that person on a WHITE or YELLOW Application Form or by giving electronic application instructions to HKSCC The refund procedures are stated in the “Despatch/Collection of and (ii) you have due authority to sign the Application Form Share Certificates and Refund Monies” in the “How to Apply for or give electronic application instructions on behalf of that Hong Kong Offer Shares” section of the Prospectus. other person as their agent. Application by HKSCC Nominees Limited (“HKSCC D. Power of attorney Nominees”) If your application is made through an authorised attorney, the Where this Application Form is signed by HKSCC Nominees Company and the Joint Global Coordinators may accept or reject on behalf of persons who have given electronic application your application at their discretion, and on any conditions they instructions to apply for the Hong Kong Offer Shares, the think fit, including evidence of the attorney’s authority. provisions of this Application Form which are inconsistent with those set out in the Prospectus shall not apply and provisions in Determination of Offer Price and Allocation of Hong Kong Offer Shares the Prospectus shall prevail. The Offer Price is expected to be fixed on or around Tuesday, Without limiting the generality of this paragraph, the following February 19, 2019. Applicants are required to pay the maximum sections of this Application Form are inapplicable where this form Offer Price of HK$12.80 for each Hong Kong Offer Share together is signed by HKSCC Nominees: with 1% brokerage, 0.0027% SFC transaction levy and 0.005% Stock • “Applicants’ declaration” on the first page; Exchange trading fee. If the Offer Price is not agreed among the • “Warning” on the first page; Company and the Joint Global Coordinators (for themselves and on • “If you are a nominee”; behalf of the Underwriters) on or before Monday, February 25, 2019, • All representations and warranties under the “Effect of the Global Offering will not proceed. completing and submitting this Application Form” section, except the first one regarding registration of Hong Kong Applications for Hong Kong Offer Shares will not be processed Offer Shares in the applicant’s name and the signing of and no allotment of any Hong Kong Offer Shares will be made documents to enable the applicant to be registered as the until the application lists close. holder of the Hong Kong Offer Shares; The Company expects to announce the fixed offer price, the • “If your application for Hong Kong Offer Shares is indication of the level of interest in the International Offering, successful (in whole or in part)”; and the level of applications under the Hong Kong Public Offering • “Refund of your money”. and the basis of allocation of the Hong Kong Offer Shares The following sections in the “How to Apply for Hong Kong Offer on Monday, February 25, 2019 on the website of the Stock Exchange at www.hkexnews.hk and the Company’s website at Shares” section of the Prospectus are inapplicable where this form is signed by HKSCC Nominees: www.cstonepharma.com . Results of allocations and the Hong • “How many applications you can make”; and Kong Identity Card/passport/Hong Kong business registration • “Circumstances in which you will not be allotted Offer numbers of successful applicants (where applicable) will be Shares”. available on the above websites. Effect of the Information You Give to Computershare Hong If your application for Hong Kong Offer Shares is successful Kong Investor Services Limited (in whole or in part) Computershare Hong Kong Investor Services Limited and its If you apply for 1,000,000 or more Hong Kong Offer Shares, related bodies corporate, directors, officers, employees and you may collect refund cheque(s) and/or share certificate(s) in agents (“ Representatives ”) expressly disclaim and exclude to the person from Computershare Hong Kong Investor Services Limited maximum extent permitted by law any liability for any loss or at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen’s damage suffered or incurred by the applicant or any other person Road East, Wanchai, Hong Kong, from 9:00 a.m. to 1:00 p.m. on or entity however caused relating in any way to, or connected Monday, February 25, 2019 or such other date notified by us in with, any information provided by or on behalf of the applicant the newspapers. on or in connection with this document or any services provided If you are an individual who is eligible for personal collection, hereunder, or any other written or oral communication provided by you must not authorise any other person to collect for you. If you or on behalf of the applicant in connection with this document or are a corporate applicant which is eligible for personal collection, any services provided hereunder. This includes, without limitation, your authorised representative must bear a letter or authorisation any errors or omissions in such information however caused, from your corporation stamped with your corporation’s chop. Both or the Representatives or any other person or entity placing individuals and authorised representatives must produce, at the time any reliance on such information or any documentation, image, of collection, evidence of identity acceptable to Computershare Hong recording or reproduction of such information, or its accuracy, completeness, currency or reliability.

If you are an individual who is eligible for personal collection, you must not authorise any other person to collect for you. If you are a corporate applicant which is eligible for personal collection, your authorised representative must bear a letter or authorisation from your corporation stamped with your corporation’s chop. Both individuals and authorised representatives must produce, at the time of collection, evidence of identity acceptable to Computershare Hong Kong Investor Services Limited.

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

==> picture [116 x 37] intentionally omitted <==

CStone Pharmaceuticals 基石藥業 （於開曼群島註冊成立的有限公司）

全球發售

• 申請條件 • 同意 本公司、有關人士及 白表eIPO 服務供應商現時及 甲、可提出申請的人士 日後均毋須對並非載於招股章程（及其任何補充文件） 1. 閣下及 閣下為其利益提出申請的人士必須年滿18歲並 的任何資料及陳述負責； 有香港地址。 • 承諾 及 確認 閣下或 閣下為其利益提出申請的人士並

• 1. 如 閣下為商號，申請須以個別成員名義提出。 無申請或接納或表示有意認購（亦不會申請或接納或表 3. 聯名申請人不得超過四名。 示有意認購）國際發售的任何發售股份，也沒有參與國 4. 如 閣下為法人團體，申請須經獲正式授權人員簽署， 際發售； 並註明其所屬代表身份及蓋上公司印鑑。 • 同意 在本公司、香港證券登記處、收款銀行及有關人
• 1. 閣下必須身處美國境外，並非美籍人士（定義見美國證 士提出要求時，向彼等披露其所要求提供有關 閣下 券法S規例）或屬美國證券法S規例第902條第(h)(3)段所 及 閣下為其利益提出申請的人士的個人資料； 述的人士，亦非中國法人或自然人。 • 若香港境外任何地方的法例適用於 閣下的申請，則 同
• 1. 除上市規則或聯交所已授予的任何相關豁免批准外，下 意 及 保證 閣下已遵守所有有關法例，且本公司及有關 列人士概不得申請認購任何香港發售股份： 人士概不會因接納 閣下的購買要約，或 閣下在招股 • 本公司及╱或其任何附屬公司股份的現有實益擁 章程及本申請表格所載的條款及條件項下的權利及責任 有人； 所引致的任何行動，而違反香港境外的任何法例；

• • 上述任何人士的緊密聯繫人； • 同意 閣下的申請一經接納，即不得因無意的失實陳述 • 本公司及╱或其任何附屬公司的董事或行政總裁； 而撤銷； • 本公司關連人士或緊隨全球發售完成後成為本公司 • 同意 閣下的申請受香港法例規管； 關連人士的人士；或 • 聲明 、 保證 及 承諾 ：(i) 閣下明白香港發售股份不曾亦

• • 已獲分配或已申請或表示有意申請國際發售的任何 不會根據美國證券法登記；及(ii) 閣下及 閣下為其 發售股份。 利益申請香港發售股份的人士均身處美國境外（定義見 S規例），或屬S規例第902條第(h)(3)段所述的人士；

• 乙、如 閣下為代名人如 閣下為代名人 • 保證 閣下提供的資料真實及準確； 閣下作為代名人可提交超過一份香港發售股份申請，方法 • 同意 接納所申請數目或根據申請分配予 閣下但數目較 是：(i)透過中央結算及交收系統（「中央結算系統」）向香港(i)透過中央結算及交收系統（「中央結算系統」）向香港透過中央結算及交收系統（「中央結算系統」）向香港 少的香港發售股份； 結算發出電子認購指示（如 閣下為中央結算系統參與者）； • 授權 本公司將 閣下的姓名╱名稱列入本公司股東名 或(ii)使用(ii)使用使用 白色 或 黃色 申請表格，以自身名義代表不同的實益 冊，作為 閣下獲分配的任何香港發售股份的持有人， 擁有人提交超過一份申請。 並授權本公司及╱或其代理以普通郵遞方式按申請所 示地址向 閣下或聯名申請的首名申請人發送任何股票

• 丙、填交本申請表格的效用填交本申請表格的效用 及╱或退款支票，郵誤風險由 閣下承擔，除非 閣 閣下填妥並遞交本申請表格，即表示 閣下（如屬聯名申請 下已符合招股章程「如何申請香港發售股份」一節「親 人，即各人共同及個別）代表 閣下本身，或作為 閣下代 身領取」所載條件親身領取股票及╱或退款支票； 其行事的每位人士的代理或代名人： • 明白 根據聯交所發出的指引信HKEX-GL91-18，當國際HKEX-GL91-18，當國際，當國際 • 承諾 簽立所有相關文件，並指示及授權本公司及╱或 發售股份認購不足而香港發售股份出現超額認購（不論 聯席全球協調人（或彼等的代理或代名人）（作為本公司 多少倍），最多18,640,000股發售股份可由國際發售重新18,640,000股發售股份可由國際發售重新股發售股份可由國際發售重新 代理），為按照組織章程細則的規定將 閣下獲分配的 配發至香港公開發售，香港公開發售可供認購股份總數 任何香港發售股份以 閣下名義登記而代表 閣下簽立 將從而增加至37,280,000股發售股份，相當於全球發售37,280,000股發售股份，相當於全球發售股發售股份，相當於全球發售 任何文件及代 閣下進行一切必要事宜； 初步提呈認購的發售股份數目約20%（於行使任何超額20%（於行使任何超額（於行使任何超額

• 除上市規則或聯交所已授予的任何相關豁免批准外，下 列人士概不得申請認購任何香港發售股份：

乙、如 閣下為代名人如 閣下為代名人 • 閣下作為代名人可提交超過一份香港發售股份申請，方法 • 是：(i)透過中央結算及交收系統（「中央結算系統」）向香港(i)透過中央結算及交收系統（「中央結算系統」）向香港透過中央結算及交收系統（「中央結算系統」）向香港 結算發出電子認購指示（如 閣下為中央結算系統參與者）； • 或(ii)使用(ii)使用使用 白色 或 黃色 申請表格，以自身名義代表不同的實益 擁有人提交超過一份申請。

丙、填交本申請表格的效用填交本申請表格的效用 閣下填妥並遞交本申請表格，即表示 閣下（如屬聯名申請 人，即各人共同及個別）代表 閣下本身，或作為 閣下代 其行事的每位人士的代理或代名人：

• 明白 根據聯交所發出的指引信HKEX-GL91-18，當國際HKEX-GL91-18，當國際，當國際 發售股份認購不足而香港發售股份出現超額認購（不論 多少倍），最多18,640,000股發售股份可由國際發售重新18,640,000股發售股份可由國際發售重新股發售股份可由國際發售重新 配發至香港公開發售，香港公開發售可供認購股份總數 將從而增加至37,280,000股發售股份，相當於全球發售37,280,000股發售股份，相當於全球發售股發售股份，相當於全球發售 初步提呈認購的發售股份數目約20%（於行使任何超額20%（於行使任何超額（於行使任何超額 配股權前），而最終發售價將定於招股章程所述的指示 性發售價格範圍下限（即每股發售股份11.10港元）。重 新配發的進一步詳情載於招股章程「全球發售的架構— 香港公開發售— 重新分配及回補機制」一段；

• 同意 遵守第622章公司條例、第32章公司（清盤及雜項 條文）條例及組織章程細則；

• 確認 閣下已細閱招股章程及本申請表格所載的條款及 條件以及申請程序，並同意受其約束；

• 確認 閣下已接獲及細閱招股章程，提出申請時也僅依 據招股章程載列的資料及陳述，而除招股章程任何補充 文件外，不會依賴任何其他資料或陳述；

• 明白 本公司及聯席全球協調人將依據 閣下的聲明及陳 述而決定是否向 閣下分配任何香港發售股份， 閣下 如作出虛假聲明，可能會被檢控；

• 聲明 及 陳述 此乃 閣下為本身或為其利益提出申請的人 士所提出及擬提出的唯一申請；

• 確認 閣下知悉招股章程內有關全球發售的限制；

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

如 閣下並無在指定領取時間內親身領取退款支票及╱或股 票，有關支票及╱股票將會立刻以普通郵遞方式寄往本申請 表格所示地址，郵誤風險由 閣下承擔。

• （如本申請為 閣下本身的利益提出） 保證 閣下或作 為 閣下代理的任何人士或任何其他人士不曾亦不會 為 閣下的利益以 白色 或 黃色 申請表格或向香港結算或 向 白表eIPO 服務供應商發出電子認購指示而提出其他 申請；及

如 閣下申請認購1,000,000股以下香港發售股份， 閣下 的退款支票及╱或股票將於二零一九年二月二十五日（星期 一）或以前以普通郵遞方式寄往相關申請表格所示地址，郵 誤風險由 閣下承擔。

• （如 閣下作為代理為另一人士的利益提出申請） 保證 一）或以前以普通郵遞方式寄往相關申請表格所示地址，郵 (i) 閣下（作為代理或為該人士利益）或該人士或任何 誤風險由 閣下承擔。 其他作為該人士代理的人士不曾亦不會以 白色 或 黃色 申 請表格或向香港結算發出電子認購指示而提出其他申 退回款項 請；及(ii) 閣下獲正式授權作為該人士的代理代為簽 若 閣下未獲分配任何香港發售股份或申請僅部分獲接納， 署本申請表格或發出電子認購指示。 本公司將不計利息退回 閣下的申請股款（包括相關的1%經 紀佣金、0.0027%證監會交易徵費及0.005%聯交所交易費）。 丁、授權書 如發售價低於最高發售價，本公司將不計利息退回多收申請 如 閣下透過授權代理人提出申請，本公司及聯席全球協調 股款（包括相關的1%經紀佣金、0.0027%證監會交易徵費及 0.005%聯交所交易費）。 人可按其認為合適的條件（包括出示獲授權證明）酌情接納 或拒絕 閣下的申請。 有關退款程序載於招股章程「如何申請香港發售股份」一節 「發送╱領取股票及退款」。 釐定發售價及香港發售股份的分配 預期發售價於二零一九年二月十九日（星期二）或前後釐 香港中央結算（代理人）有限公司（「香港結算代理人」）提出 定。申請人須繳付每股香港發售股份12.80港元的最高發售 的申請 價，另加1%經紀佣金、0.0027%證監會交易徵費及0.005%聯 如本申請表格由香港結算代理人代表發出電子認購指示申請 交所交易費。倘若本公司與聯席全球協調人（為其本身及代 香港發售股份的人士簽署，本申請表格與招股章程不符的條 表包銷商）並無於二零一九年二月二十五日（星期一）或之前 文將不適用，且以招股章程所述者為準。 協定發售價，全球發售將不會進行。 在不限制此段一般應用的前提下，本申請表格的以下部分在 香港結算代理人作簽署人的情況下並不適用： 截止登記認購申請前，概不處理香港發售股份的申請或配發 • 第一頁的「申請人聲明」； 任何香港發售股份。 • 第一頁的「警告」； • 「如 閣下為代名人」； 本公司預期於二零一九年二月二十五日（星期一） • 「填交本申請表格的效用」一節項下的所有陳述及保 在聯交所網站( www.hkexnews.hk )及本公司網站 證，惟首項有關以申請人名義登記香港發售股份及簽署 ( www.cstonepharma.com )公佈協定發售價、國際發售踴躍程 使申請人登記成為香港發售股份持有人的文件除外； 度、香港公開發售認購申請數目及香港發售股份分配基準。 • 「如 閣下成功申請認購香港發售股份（全部或部 分配結果以及獲接納申請人的香港身份證╱護照╱香港商 分）」；及 業登記號碼（如適用）亦同於上述網站公佈。 • 「退回款項」。 如 閣下成功申請認購香港發售股份（全部或部分） 招股章程「如何申請香港發售股份」一節的以下部分在香港 結算代理人作簽署人的情況下並不適用： 如 閣下申請認購1,000,000股或以上香港發售股份， 閣 • 「閣下可提交的申請數目」；及 下可於二零一九年二月二十五日（星期一）或吾等於報章通 • 「閣下不獲配發發售股份的情況」。 知的其他日期上午九時正至下午一時正自香港中央證券登記 有限公司（地址為香港灣仔皇后大道東183號合和中心17樓 閣下提供給香港中央證券登記有限公司的資料的有關影響 1712-1716室）領取退款支票及╱或股票。 香港中央證券登記有限公司和其有關聯的法人團體、董事、 高級人員、僱員及代理人（「 代表 」）在法律所容許的最大限 如 閣下為個人申請人並合資格親身領取， 閣下不得授權 度內明確卸棄及免除在任何方面與申請人或代表申請人在此 任何其他人士代領。如 閣下為公司申請人並合資格派人領 文件提供的或與此文件或在此文件下提供的任何服務相關的 取， 閣下的授權代表須攜同蓋上公司印鑑的授權書領取。 任何資料，或任何申請人或代表申請人提供與此文件或在此 個人申請人及授權代表領取股票時均須出示香港中央證券登 文件下提供的任何服務相關的任何其他書面或口頭通訊，有 記有限公司接納的身份證明文件。 關或相關由申請人或任何其他人士或實體所遭受或招致不論 如何造成的任何損失或損害的任何法律責任。此包括，但不 限於，該等資料中不論如何造成的任何錯誤或遺漏，或代表 或任何其他人士或實體對該等資料或任何該等資料的文件記 錄、影像、記錄或複製品作出的任何依據，或其準確性、完 整性、合時性或可靠性。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

Personal Data

3. Transfer of personal data Personal data held by the Company and its Hong Kong Share Registrar relating to the securities holders will be kept confidential but the Company and its Hong Kong Share Registrar may, to the extent necessary for achieving any of the above purposes, disclose, obtain or transfer (whether within or outside Hong Kong) the personal data to, from or with any of the following:

Personal Information Collection Statement

This Personal Information Collection Statement informs the applicant for, and holder of, Hong Kong Offer Shares, of the policies and practices of the Company and its Hong Kong Share Registrar in relation to personal data and the Personal Data (Privacy) Ordinance (Cap. 486) (the “Ordinance”).

• the Company’s appointed agents such as financial

1. Reasons for the collection of your personal data the Company’s appointed agents such as financial It is necessary for applicants and registered holders of advisers, receiving bankers and overseas principal securities to supply correct personal data to the Company share registrar; or its agents and the Hong Kong Share Registrar when • where applicants for securities request a deposit into applying for securities or transferring securities into or out CCASS, HKSCC or HKSCC Nominees, who will of their names or in procuring the services of the Hong use the personal data for the purposes of operating Kong Share Registrar. CCASS; • any agents, contractors or third-party service providers Failure to supply the requested data may result in your who offer administrative, telecommunications, application for securities being rejected, or in delay or the computer, payment or other services to the Company or inability of the Company or its Hong Kong Share Registrar the Hong Kong Share Registrar in connection with their to effect transfers or otherwise render their services. It respective business operation; may also prevent or delay registration or transfers of the • the Stock Exchange, the SFC and any other statutory Hong Kong Offer Shares which you have successfully regulatory or governmental bodies or otherwise as applied for and/or the dispatch of share certificate(s) required by laws, rules or regulations; and and/or refund cheque(s) to which you are entitled. • any persons or institutions with which the securities’ holders have or propose to have dealings, such as It is important that securities holders inform the Company their bankers, solicitors, accountants or stockbrokers and the Hong Kong Share Registrar immediately etc. inaccuracies in the personal data supplied. 4. Retention of personal data 2. Purposes The Company and its Hong Kong Share Registrar will The personal data of the securities holders may be used, keep the personal data of the applicants and holders of held, processed, and/or stored (by whatever means) for the securities for as long as necessary to fulfil the purposes following purposes: for which the personal data were collected. Personal data • processing your application and refund cheque, where which is no longer required will be destroyed or dealt with applicable, verification of compliance with the terms in accordance with the Ordinance. and application procedures set out in this Application Form and the Prospectus and announcing results of 5. Access to and correction of personal data allocation of the Hong Kong Offer Shares; Securities holders have the right to ascertain whether the • compliance with applicable laws and regulations in Company or the Hong Kong Share Registrar hold their Hong Kong and elsewhere; personal data, to obtain a copy of that data, and to correct • registering new issues or transfers into or out of any data that is inaccurate. The Company and the Hong the names of securities’ holders including, where Kong Share Registrar have the right to charge a reasonable applicable, HKSCC Nominees; fee for the processing of such requests. • maintaining or updating the register of securities’ holders of the Company; All requests for access to data or correction of data should • verifying securities holders’ identities; • establishing benefit entitlements of securities’ holders be addressed to us, at our registered address disclosed in the “Corporate Information” section of the Prospectus of the Company, such as dividends, rights issues, or as notified from time to time, for the attention of the bonus issues, etc.; • distributing communications from the Company and company secretary, or our Hong Kong Share Registrar for the attention of the privacy compliance officer.

• The personal data of the securities holders may be used, held, processed, and/or stored (by whatever means) for the following purposes: • processing your application and refund cheque, where applicable, verification of compliance with the terms and application procedures set out in this Application Form and the Prospectus and announcing results of allocation of the Hong Kong Offer Shares;

• • compliance with applicable laws and regulations in Hong Kong and elsewhere;

• • registering new issues or transfers into or out of the names of securities’ holders including, where applicable, HKSCC Nominees;

• • maintaining or updating the register of securities’ holders of the Company;

• • verifying securities holders’ identities;

• distributing communications from the Company and its subsidiaries;

• compiling statistical information and securities’ holder profiles;

By signing an Application Form or by giving electronic application instructions to HKSCC, you agree to all of the above.

• disclosing relevant information to facilitate claims on entitlements; and

• any other incidental or associated purposes relating to the above and/or to enable the Company and the Hong Kong Share Registrar to discharge their obligations to securities’ holders and/or regulators and/or any other purposes to which the securities’ holders may from time to time agree.

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

個人資料

3. 轉交個人資料 本公司及其香港證券登記處所持有關證券持有人的 個人資料將會保密，但本公司及其香港證券登記處 可以在為達到上述任何目的之必要情況下，向下列 任何人士披露，獲取或轉交（無論在香港境內或境 外）有關個人資料：

個人資料收集聲明

此項個人資料收集聲明是向香港發售股份的申請人 本公司及其香港證券登記處所持有關證券持有人的 和持有人說明有關本公司及其香港證券登記處有關 個人資料將會保密，但本公司及其香港證券登記處 個人資料和第486章《個人資料（私隱）條例》（「條 可以在為達到上述任何目的之必要情況下，向下列 例」）方面的政策和慣例。 任何人士披露，獲取或轉交（無論在香港境內或境 外）有關個人資料： 1. 收集 閣下個人資料的原因 • 本公司委任的代理人，例如財務顧問、收款銀 證券申請人及登記持有人以本身名義申請證券或轉 行和主要海外股份過戶登記分處； 讓或受讓證券時或尋求香港證券登記處的服務時， • （如證券申請人要求將證券存於中央結算系統） 必須向本公司或其代理人及香港證券登記處提供準 香港結算或香港結算代理人；彼等將會就中央 確個人資料。 結算系統的運作使用有關個人資料； • 向本公司或香港證券登記處提供與其各自業務 未能提供所要求的資料可能導致 閣下申請證券被 營運有關的行政、電訊、電腦、付款或其他服 拒或延遲，或本公司或其香港證券登記處無法落實 務的任何代理人、承包商或第三方服務供應 轉讓或提供服務。此舉也可能妨礙或延遲登記或轉 商； 讓 閣下成功申請的香港發售股份及╱或寄發 閣 • 聯交所、證監會及任何其他法定監管機關或政 下應得的股票及╱或退款支票。 府部門或遵照其他法例、規則或法規；及 • 證券持有人與其進行或擬進行交易的任何人士 證券持有人所提供的個人資料如有任何錯誤，須立 或機構，例如彼等的銀行、律師、會計師或股 即通知本公司及香港證券登記處。 票經紀等。 2. 目的 4. 個人資料的保留 證券持有人的個人資料可被採用及以任何方式持 本公司及其香港證券登記處將按收集個人資料所需 有、處理及╱或保存，以作下列用途： 的用途保留證券申請人及持有人的個人資料。無需 • 處理 閣下的申請及退款支票（如適用）、核實 保留的個人資料將會根據條例銷毀或處理。 是否符合本申請表格及招股章程載列的條款和 申請程序以及公佈香港發售股份的分配結果； 5. 查閱和更正個人資料 • 遵守香港及其他地區的適用法律及法規； 證券持有人有權確定本公司或香港證券登記處是否 • 以證券持有人（包括香港結算代理人（如適 持有其個人資料，並有權索取有關該資料的副本並 用））的名義登記新發行證券或轉讓或受讓證 更正任何不準確資料。本公司和香港證券登記處有 券； 權就處理任何查閱資料的要求收取合理費用。 • 存置或更新本公司證券持有人的名冊； • 核實證券持有人的身份； 所有查閱資料或更正資料的要求應按招股章程「公 • 確定本公司證券持有人的受益權利，例如股 司資料」一節所披露或不時通知的本公司註冊地址 息、供股和紅股等； 送交公司秘書，或向本公司的香港證券登記處的個

所有查閱資料或更正資料的要求應按招股章程「公 司資料」一節所披露或不時通知的本公司註冊地址 送交公司秘書，或向本公司的香港證券登記處的個 人資料私隱事務主任提出。

• 分發本公司及其附屬公司的通訊；

• 編製統計數據和證券持有人資料；

• 披露有關資料以便就權益索償；及

• 與上述有關的任何其他附帶或相關目的及╱或 使本公司及香港證券登記處能履行對證券持有 人及╱或監管機構承擔的責任及╱或證券持有 人不時同意的任何其他目的。

閣下簽署申請表格或向香港結算發出電子認購指 示，即表示同意上述各項。